The cross-species mycobacterial growth inhibition assay (MGIA) project 2010-2014

The cross-species mycobacterial growth inhibition assay (MGIA) project 2010-2014

The development of a functional biomarker assay in the tuberculosis (TB) field would be widely recognized as a major advance in efforts to efficiently develop and test novel TB vaccine candidates. We present preliminary studies using mycobacterial growth inhibition assays (MGIAs) to detect a BCG vac...

Повний опис

Бібліографічні деталі
Автори:	Brennan, M, Tanner, R, Morris, S, Scriba, T, Achkar, J, Zelmer, A, Hokey, D, Izzo, A, Sharpe, S, Williams, A, Penn-Nicholson, A, Erasmus, M, Stylianou, E, Hoft, D, McShane, H, Fletcher, H
Формат:	Journal article
Опубліковано:	American Society for Microbiology 2017

Схожі ресурси

Assessment of the reproducibility and inter-site transferability of the murine direct splenocyte mycobacterial growth inhibition assay (MGIA)
за авторством: Tanner, R, та інші
Опубліковано: (2021)

A mycobacterial growth inhibition assay (MGIA) for bovine TB vaccine development
за авторством: Pepponi, I, та інші
Опубліковано: (2017)

A new tool for tuberculosis vaccine screening: Ex vivo Mycobacterial Growth Inhibition Assay indicates BCG mediated protection in a murine model of tuberculosis
за авторством: McShane, H, та інші
Опубліковано: (2016)

Demonstrating the utility of the ex vivo murine mycobacterial growth inhibition assay (MGIA) for high-throughput screening of tuberculosis vaccine candidates against multiple Mycobacterium tuberculosis complex strains
за авторством: Painter, H, та інші
Опубліковано: (2024)

The in vitro direct mycobacterial growth inhibition assay (MGIA) for the early evaluation of TB vaccine candidates and assessment of protective immunity: a protocol for non-human primate cells
за авторством: Tanner, R, та інші
Опубліковано: (2021)

The in vitro direct mycobacterial growth inhibition assay (MGIA) for the early evaluation of TB vaccine candidates and assessment of protective immunity: a protocol for non-human primate cells [version 2; peer review: 2 approved]
за авторством: Rachel Tanner, та інші
Опубліковано: (2021-09-01)

Development and application of the direct mycobacterial growth inhibition assay: a systematic review
за авторством: Painter, H, та інші
Опубліковано: (2024)

Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb)
за авторством: Marsay, L, та інші
Опубліковано: (2013)

Development and application of the direct mycobacterial growth inhibition assay: a systematic review
за авторством: Hannah Painter, та інші
Опубліковано: (2024-02-01)

The influence of haemoglobin and iron on in vitro mycobacterial growth inhibition assays
за авторством: Tanner, R, та інші
Опубліковано: (2017)

Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb).
за авторством: Marsay, L, та інші
Опубліковано: (2013)

Adaption of the ex vivo mycobacterial growth inhibition assay for use with murine lung cells
за авторством: Painter, H, та інші
Опубліковано: (2020)

Association of human antibodies to arabinomannan with enhanced mycobacterial opsonophagocytosis and intracellular growth reduction
за авторством: McShane, H, та інші
Опубліковано: (2016)

In vitro mycobacterial growth inhibition assays: A tool for the assessment of protective immunity and evaluation of tuberculosis vaccine efficacy
за авторством: Mcshane, H, та інші
Опубліковано: (2017)

Immunological correlates of mycobacterial growth inhibition describe a spectrum of tuberculosis infection
за авторством: O'Shea, M, та інші
Опубліковано: (2018)

Adaption of the ex vivo mycobacterial growth inhibition assay for use with murine lung cells
за авторством: Hannah Painter, та інші
Опубліковано: (2020-02-01)

Inhibition of mycobacterial growth in vitro following primary but not secondary vaccination with Mycobacterium bovis BCG.
за авторством: Fletcher, H, та інші
Опубліковано: (2013)

Regulation of mycobacterial infection by macrophage Gch1 and tetrahydrobiopterin
за авторством: McNeill, E, та інші
Опубліковано: (2018)

Tools for assessing the protective efficacy of TB vaccines in humans: in vitro mycobacterial growth inhibition predicts outcome of in vivo mycobacterial infection
за авторством: Tanner, R, та інші
Опубліковано: (2020)

Evaluating the effect of BCG vaccination on a whole-blood mycobacterial growth inhibition assay (BACTEC MGIT)
за авторством: Tanner, R, та інші
Опубліковано: (2011)

Distinct transcriptional and anti-mycobacterial profiles of peripheral blood monocytes dependent on the ratio of monocytes: lymphocytes
за авторством: Naranbhai, V, та інші
Опубліковано: (2015)

Optimising immunogenicity with viral vectors: mixing MVA and HAdV-5 expressing the mycobacterial antigen Ag85A in a single injection
за авторством: Betts, G, та інші
Опубліковано: (2012)

Regulation of mycobacterial infection by macrophage Gch1 and tetrahydrobiopterin
за авторством: Eileen McNeill, та інші
Опубліковано: (2018-12-01)

Application of a whole blood mycobacterial growth inhibition assay to study immunity against Mycobacterium tuberculosis in a high tuberculosis burden population.
за авторством: Richard Baguma, та інші
Опубліковано: (2017-01-01)

Distinct Transcriptional and Anti-Mycobacterial Profiles of Peripheral Blood Monocytes Dependent on the Ratio of Monocytes: Lymphocytes
за авторством: Vivek Naranbhai, та інші
Опубліковано: (2015-11-01)

Human hookworm infection enhances mycobacterial growth inhibition and associates with reduced risk of tuberculosis infection
за авторством: O'Shea, M, та інші
Опубліковано: (2018)

RUTI Vaccination Enhances Inhibition of Mycobacterial Growth ex vivo and Induces a Shift of Monocyte Phenotype in Mice
за авторством: Satria A. Prabowo, та інші
Опубліковано: (2019-04-01)

Identification of novel mycobacterial antigens presented by MHC-I and -II by immunopeptidomics for vaccines against tuberculosis
за авторством: Bettencourt, P, та інші
Опубліковано: (2019)

Optimisation, harmonisation and standardisation of the direct mycobacterial growth inhibition assay using cryopreserved human peripheral blood mononuclear cells
за авторством: Tanner, R, та інші
Опубліковано: (2019)

Evaluation of immune profiles associated with control of mycobacterial growth in systemic lupus erythematosus (SLE) patients
за авторством: Ongarj, J, та інші
Опубліковано: (2024)

Historical BCG vaccination combined with drug treatment enhances inhibition of mycobacterial growth ex vivo in human peripheral blood cells
за авторством: Prabowo, SA, та інші
Опубліковано: (2019)

Gene expression and cytokine profile correlate with mycobacterial growth in a human BCG challenge model
за авторством: Matsumiya, M, та інші
Опубліковано: (2014)

Impaired IFN-gamma-secreting capacity in mycobacterial antigen-specific CD4 T cells during chronic HIV-1 infection despite long-term HAART.
за авторством: Sutherland, R, та інші
Опубліковано: (2006)

Identification of antigens specific to non-tuberculous mycobacteria: the Mce family of proteins as a target of T cell immune responses.
за авторством: Checkley, A, та інші
Опубліковано: (2011)

Cholera toxin enhances vaccine-induced protection against Mycobacterium tuberculosis challenge in mice
за авторством: Griffiths, K, та інші
Опубліковано: (2013)

Development of mycobacterial growth inhibition assays for the early evaluation and gating of novel TB vaccine candidates
за авторством: Tanner, R
Опубліковано: (2015)

In vitro Mycobacterial Growth Inhibition in South Korean Adults With Latent TB Infection
за авторством: Hyejon Lee, та інші
Опубліковано: (2019-04-01)

Replacing, reducing and refining the use of animals in tuberculosis vaccine 1 research
за авторством: Tanner, R, та інші
Опубліковано: (2016)

Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations
за авторством: Hanekom, W, та інші
Опубліковано: (2008)

Human Hookworm Infection Enhances Mycobacterial Growth Inhibition and Associates With Reduced Risk of Tuberculosis Infection
за авторством: Matthew K. O'Shea, та інші
Опубліковано: (2018-12-01)